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Esophageal motility disturbances are common in diabetics in general and are most prevalent
in these with peripheral neuropathy or autonomic neuropathy. The usual findings are a
decrease in the amplitude of esophageal contractions in the smooth muscle portion of the
body, frequent absence of primary peristalsis, simultaneous or repetitive body contractions,
and a decrease in the velocity of peristalsis. Radiographically, this may be manifest as delayed
esophageal emptying. These changes do not produce symptoms. Dysphagia and chest pain
should be thoroughly evaluated and not ascribed to the diabetes. Candidiasis may be more
common in diabetics.
In the past ten years there has been considerable interest in the study of
esophageal function in patients with diabetes mellitus. This has primarily resulted
(1) from the knowledge that esophageal motility is likely to be affected by diabetic
neuropathy, and (2) from the accessibility of the esophagus. However, it should be
noted that clinical evidence ofesophageal dysfunction is not an important complica-
tion of diabetes. In this chapter four questions will be addressed. (1) What is the
prevalence of esophageal motor dysfunction in diabetes? (2) What are its clinical
features? (3) What is the pathogenesis of this motor disorder? and, (4) Are other
esophageal diseases also found in diabetes?
What is the prevalence of esophageal motor dysfunction in diabetics?
Mandelstam and Lieber were the first to survey a group of diabetics for evidence
of esophageal involvement [1]. They reported that the emptying of barium from the
esophagus was delayed in nearly all diabetics with peripheral neuropathy. Later,
they found that this group also exhibited a decrease in the frequency of peristaltic
contractions after swallowing. Ten years later, in a larger study, Hollis et al. found
that 80 percent of diabetics with peripheral neuropathy had abnormal esophageal
motility [2]. In contrast, only 20 percent ofdiabetics without neuropathy had abnor-
mal esophageal motility.
In general, the esophageal changes in diabetes can be described as a loss of mo-
tility. (1) Pressures are lower in the smooth muscle portion of the esophagus. The
amplitude of esophageal body contractions tends to be low, as does the lower
esophageal sphincter pressure. (2) The velocity of esophageal body contraction is
reduced. The time required for peristalsis to sweep down the esophagus is pro-
longed. (3) The pattern of esophageal body contractions may show the following:
absence of contraction after swallowing, and simultaneous or repetitive body con-
tractions. Associated with the loss ofmotility is an impairment in esophageal empty-
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All rights of reproduction in any form reserved.ing, and the esophageal transit time for barium [2] and for water labeled with a
radioisotope [3] is increased in diabetes. These changes, though, are not specific for
diabetes, but can also be seen in reflux esophagitis, scleroderma, alcoholic
neuropathy, intestinal pseudobstruction, and other diseases.
It seems that the more severe the neuropathy, the greater the likelihood of
esophageal involvement. Virtually all patients with autonomic dysfunction, whether
gastrointestinal, vascular, or genitourinary, have abnormalities of esophageal
motility. However, in patients with peripheral neuropathy without symptoms of
autonomic involvement, only 50 percent have esophageal abnormalities [3].
What are the clinical features of esophageal motor dysfunction in diabetes?
The esophageal motility changes ofloss of peristalsis and delayed transit would be
likely to produce dysphagia or esophagitis. The latter is theorized, since impaired
clearance of acid is an important feature of reflux esophagitis. However, most
studies agree that esophageal symptoms are quite uncommon in diabetics. In the
study by Hollis et al., while 56 percent of the diabetics had abnormal motility, only
one of 50 had frequent heartburn. In that study, as well as in several other large
surveys, few patients complained of dysphagia. In fact, dysphagia is so uncommon
in diabetics that when present an exhaustive search should be made to exclude the
usual causes of dysphagia rather than ascribing that symptom to diabetes.
What is the pathogenesis of these motility abnormalities?
The esophagus, like the rest of the gastrointestinal tract, responds to vagal
stimulation. The principal effects ofthe vagus are relaxation ofthe lower esophageal
sphincter and peristalsis throughout the esophagus from the proximal striated mus-
cle portion to the distal smooth muscle portion. However, vagotomy does not pro-
duce any characteristic alterations of esophageal motility. Both peristalsis and
sphincter relaxation remain intact in the externally denervated esophagus. The
myenteric plexuses within the esophageal wall act as the "brain of the esophagus"
and, in response to local afferent stimuli, coordinate peristalsis and relaxation. By
way of comparison, the myenteric plexuses have a similar function in the rest of the
gastrointestinal tract, but vagotomy results in distinctive alterations in gastric relax-
ation and small bowel digestive myo-electric activity.
In diabetes the neuropathologic alterations in the esophagus, as described by
Smith, are (1) Schwann cell loss in the parasympathetic fibers, both in the wall and
in extrinsic nerves; (2) demyelination and Wallerian change in the vagus; and (3)
preservation of the myenteric plexus [4]. These findings are consistent with the
manometric features of diabetes. Parasympathetic cholinergic stimulation in man
seems to be primarily involved with peristalsis. Thus, the observation of a slowing of
peristalsis would be compatible with a loss of cholinergic stimulation. Hollis et al.
have shown that the muscle itself responds to cholinergic stimulation appropriately.
Since the myenteric plexus, which has a major role in the regulation of esophageal
motility, is normal in diabetes, esophageal function is sufficiently preserved to pre-
vent dysphagia.
Are other esophageal diseases also found in diabetes?
CANDIDIASIS
Diabetes is felt to be a predisposing condition for candida esophagitis. Most texts
list the association without reference. In fact, it may be that, due to the known
predilection for diabetics to develop vaginal or oral thrush, esophageal disease has
been inferred. In one series of prospective patients in which smears were taken from
the esophagus at endoscopy, three of 27 patients with candida were diabetics [5].
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The diagnosis ofcandida esophagitis is established by the appearance ofraisedwhite
plaques on the mucosa, which on smear contained buds or hyphae. Cultures from
the esophagus are not worthwhile, as two-thirds ofcontrol patients can have positive
cultures. The measurement ofagglutinin titers to candida in sera is helpful, as a titer
of 1/160 or greater is found in 100 percent ofcandidiasis cases and up to 17 percent
of controls.
There are two treatment modalities; one is nystatin (Mycostatin), 800,000 units,
three to four times a day. It can be given as mouthwash, gargle and swallow, or
suspended in 1 percent methyl cellulose to enhance its adherence to the wall [6]. The
other option is the use of Ketoconazole, 200 mg daily. This agent is well-tolerated,
and compliance may be better than with nystatin.
DIFFUSE INTRAMURAL ESOPHAGEAL PSEUDODIVERTICULOSIS
This is an uncommon esophageal condition in which multiple out-pouchings from
the esophageal wall are found (Fig. 1). It may be localized or diffuse. The diffuse
condition is more relevant clinically, presenting with dysphagia due to an associated
stricture in most cases [7]. The stricture is unique in that most are found in the upper
third of the esophagus. At times the mucosal ulcerations in a severe candida
esophagitis can be confused with this entity. It is thought that a co-existent inflam-
matory process obstructs the mucus glands in the esophageal wall leading to dilata-
tion and the appearance ofdiverticula. The course is benign, with treatment directed
to the underlying esophagitis and stricture. As of 1977, ofthe 29 reported cases, five
were diabetics. This is probably a chance association.
SUMMARY
Neuropathic complications in diabetes frequently result in a mild loss of
esophageal contraction amplitude, a slowing of the velocity of peristalsis, and a
1 FIG. 1.
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resultant delay in esophageal emptying. But more severe abnormalities are uncom-
mon, and that degree of esophageal motor change does not cause symptoms. When
dysphagia or chest pain occur in diabetics, they should be thoroughly investigated
with X-ray, endoscopy, and, if warranted, motility. The only condition which prob-
ably occurs with greater frequency in diabetes is esophageal candidiasis.
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